For our customers: COVID-19 Response Series

The ongoing COVID-19 pandemic has changed the way in which the global economy functions, including the life sciences industry. It has pushed us to think about performing the same jobs in different ways. It has pushed us to reimagine the way we train, learn and grow in a remote work environment.

ACTO’s raison d’être is to help global pharmaceutical and medical device companies promote on clinical value to increase sales, drive brand alignment, and reduce compliance risk. During times like these, ACTO is committed to its customers’ success by helping them with their current challenge of remotely engaging and upskilling their reps.

How is ACTO helping its customers?

As a commercial leader, you are constantly thinking of ways to upskill your reps, but how can you ensure your reps continue to reach customers remotely? And where do you start?

To help you answer these questions and more, ACTO has launched its COVID-19 Response Series for all ACTO customers. The series includes a weekly ActionPack with best practices for managing your market access and commercial strategies in this new environment.

Here are three ways you can leverage ACTO to manage the changes taking place:

1) Keep your team up to date on COVID-19 with our COVID-19 ActionPack template that covers information about the virus, preventative measures, and treatment.

2) Upskill yourself and your teams remotelywith micro-learning. Our Customer Success team is creating a series of ActionPacks to help leaders upskill themselves and their sales reps. The goal of these ActionPacks is to help you navigate through virtual training and remote team management.